Vistin Pharma ASA (VISTN.XOSL) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | kr 452 | kr 430 | kr 435 | kr 288 | kr 276 |
| Cost of Revenue | kr 220 | kr 150 | kr 233 | kr 200 | kr 144 |
| Gross Profit | kr 232 | kr 280 | kr 202 | kr 88 | kr 132 |
| Total Operating Expenses | kr 140 | kr 194 | kr 134 | kr 94 | kr 99 |
| Operating Income | kr 92 | kr 85 | kr 69 | -kr 6 | kr 33 |
| Non-Operating | |||||
| Net Interest Expense | -kr 2 | -kr 14 | -kr 2 | -kr 2 | -kr 0 |
| Income Tax Expense | kr 21 | kr 18 | kr 13 | -kr 1 | kr 7 |
| Net Income | |||||
| Net Income | kr 75 | kr 63 | kr 46 | -kr 5 | kr 25 |
| Per Share Data | |||||
| Revenue Per Share | kr 10.20 | kr 9.69 | kr 9.82 | kr 6.49 | kr 6.22 |
| EPS (Basic) | kr 1.69 | kr 1.42 | kr 1.03 | -kr 0.11 | kr 0.56 |
| EPS (Diluted) | kr 1.69 | kr 1.42 | kr 1.03 | -kr 0.11 | kr 0.56 |
| Shares Outstanding | 44.3M | 44.3M | 44.3M | 44.3M | 44.3M |
| Dividends Per Share | kr 1.00 | kr 1.75 | kr 1.25 | kr 0.00 | kr 0.00 |
Related stocks: Drug Manufacturers - Specialty & Generic
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.